Product Information
RIVASTIGMINE 3 MG CAPSULE is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.1494 per EA under NDC 72241001203. Its NADAC has been published 218 times since Jun 22, 2022.
FDA first approved this application on Feb 13, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241001203
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203844FDA Approved
2/13/2017
TE Code
AB
On Market Since
10/5/2021
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 3 MG CAPSULE has been published 218 times since Jun 22, 2022, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1494 per EA |
|---|---|
| All-time high | $0.2557 (Jan 11, 2023) |
| All-time low | $0.1451 (Jul 17, 2024) |
| 52-week high | $0.2016 |
| 52-week low | $0.1494 |
| Median price | $0.1955 |
| Average price | $0.1960 |
| Largest weekly change | +26.4% (Nov 22, 2023) |
| Weeks tracked | 218 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 3 MG CAPSULE, manufactured by Modavar Pharmaceuticals LLC, is $0.1494 per EA (NDC 72241001203), effective Aug 19, 2026.
How has the price of RIVASTIGMINE 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 3 MG CAPSULE has declined 32.5%. It has been tracked across 218 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 3 MG CAPSULE?
Since Jun 22, 2022, the NADAC for RIVASTIGMINE 3 MG CAPSULE has ranged from a low of $0.1451 (Jul 17, 2024) to a high of $0.2557 (Jan 11, 2023), with a median of $0.1955 per EA.
Are there cheaper alternatives to RIVASTIGMINE 3 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures RIVASTIGMINE 3 MG CAPSULE?
RIVASTIGMINE 3 MG CAPSULE (NDC 72241001203) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.